36 completed, 2 recruiting, 1 not yet recruiting, 1 unknown. 41 Phase 1, 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 41 | Completed 36, Recruiting 2, Not yet recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 7 | Completed 7 |
Follow Nicotine: new trials by email Literature Review of Nicotine trials Research Report on Nicotine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Sweeteners on the Addictive Threshold of Nicotine Nicotine 0.05 mg/pulse and 0.1 mg/pulse, Saline Placebo (0.5mL injection), sucralose - Smoking ( Cigarette) | Phase 1 | Not yet recruiting | Yale University | 36 | 2026-09-01 | 2026-08-31 |
| Comparative Evaluation of Nicotine Analogs Biospecimen Collection, Nicotine, 6-Methyl Nicotine - Tobacco-Related Carcinoma, Addiction | Phase 1 | Recruiting | Ohio State University Comprehensive Cancer Center | 70 | 2026-05-29 | 2026-06-26 |
| Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine (S)-Nicotine, (R)- nicotine, Racemic nicotine - Nicotine Dependence, Nicotine Vaping | Phase 1 | Recruiting | University of California, San Francisco | 18 | 2024-12-06 | 2026-05-14 |
| Effects of E-cigarette Flavors on Youth TCORS 2.0 Flavoring Agents, Nicotine - Nicotine Use Disorder | Phase 1 | Completed | Yale University | 42 | 2022-11-07 | 2024-08-09 |
| Acute Pharmacokinetic and Pharmacodynamic Effects of "Tobacco-Free" Oral Nicotine Pouches in Smokers Nicotine, Cigarette - Nicotine Withdrawal, Nicotine Addiction | Phase 1 | Completed | Johns Hopkins University | 71 | 2022-07-27 | 2026-07-23 |
| Effects of Menthol in E-cigarettes on Smoking Behaviors Nicotine - Nicotine Dependence | Phase 1 | Completed | Yale University | 14 | 2022-05-10 | 2026-06-16 |
| Nicotine Differences in Smokers 0.05, 0.025, and 0.0125 mg nicotine/pulse of nicotine, Saline - Nicotine Dependence | Phase 1 | Completed | Yale University | 11 | 2022-02-16 | 2023-12-11 |
| A Bioequivalence Study of 21 Milligram (mg) Nicotine Transdermal Patches (NicoDerm CQ, GlaxoSmithKline [GSK] Dungarvan) Compared to the Current Marketed 21 mg Nicotine Transdermal Patches (NicoDerm CQ, Alza) in Healthy Adult Smokers NicoDerm CQ patch (GSK Dungarvan), NicoDerm CQ (Alza) - Tobacco Use Disorder | Phase 1 | Completed | HALEON | 22 | 2021-09-01 | 2024-03-21 |
| Behavioral Pharmacology of Cannabis and Nicotine Cannabis, Nicotine - Cannabis, Nicotine | Phase 1 | Completed | Johns Hopkins University | 26 | 2020-09-15 | 2024-04-17 |
| Effects of E-Cigarette Flavors on Adults TCORS 2.0 Nicotine, Flavor - Nicotine Use Disorder | Phase 1 | Completed | Yale University | 130 | 2019-05-14 | 2025-12-19 |
| Effects of Commonly Used Medications on Mood and Choice Placebo, Methylphenidate, Nicotine - Healthy | Phase 1 | Completed | Johns Hopkins University | 25 | 2018-10-02 | 2026-02-02 |
| The Use of AVL-3288 to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine Placebo, Nicotine, AVL-3288 - Cognitive Change | Phase 1 | Withdrawn | University of Maryland, Baltimore | 2018-05-01 | 2024-11-06 | |
| Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 2 Nicotine, Experimental Flavor, Menthol Flavor - Nicotine Dependence | Phase 1 | Completed | Yale University | 56 | 2017-05-02 | 2020-05-04 |
| Neuroimaging Reward, Behavioral Treatment, and Smoking Cessation Nicotine Patch, SPECTRUM Nicotine Research Cigarettes (.03 mg), Behavioral Activation - Smoking | Phase 1 / Phase 2 | Completed | Maggie M Sweitzer, PhD | 35 | 2017-02-01 | 2022-06-28 |
| Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study Habitrol, Placebo to Habitrol - Sarcoidosis | Phase 1 / Phase 2 | Completed | Ohio State University | 50 | 2015-10-21 | 2025-04-24 |
| Flavors and E-cigarette Effects in Adolescent Smokers- STUDY 1 Nicotine, Low Dose Menthol, High Dose Menthol - Nicotine Dependence, Other Tobacco Product | Phase 1 | Completed | Yale University | 59 | 2014-10-23 | 2020-05-04 |
| Pharmacokinetics and Acute Effects of Multiple Dose of Nicotine: Electronic Cigarette and Cigarette Nicotine - Nicotine Use Disorder | Phase 1 | Completed | Parc de Salut Mar | 12 | 2014-10-01 | 2015-07-30 |
| Effects of Hallucinogens and Other Drugs on Mood and Performance Hallucinogens and psychoactive substances - Healthy | Phase 1 | Completed | Johns Hopkins University | 20 | 2014-04-01 | 2019-05-16 |
| Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans Cocaine hydrochloride, Exercise, Nicotine - Cocaine Dependence | Phase 1 | Completed | Yale University | 5 | 2013-10-01 | 2023-02-16 |
| Pilot Pharmacokinetic Study of Investigational Sublingual Nicotine Tablet Versus COMMIT Nicotine Lozenge Nicotine (Pharmaceutical Productions Inc.) - Nicotine Pharmacokinetic Study | Phase 1 | Completed | Pharmaceutical Productions Inc. | 6 | 2013-06-01 | 2016-03-30 |
Showing 20 of 41. Sign in to see all of them.
Tobacco Use Disorder (15) · Smoking (8) · Smoking Cessation (5) · Cigarette Smoking (3) · Vaping (3) · Cognitive Dysfunction (2) · Substance-Related Disorders (2) · Alzheimer Disease (1) · Behavior, Addictive (1) · Cocaine-Related Disorders (1) · Cognition Disorders (1) · Consciousness Disorders (1) · Dementia (1) · Down Syndrome (1) · Marijuana Abuse (1)
Yale University (11) · GlaxoSmithKline (5) · Johns Hopkins University (4) · National Institute on Drug Abuse (NIDA) (3) · Contract Research Organization el AB (1) · HALEON (1) · Maggie M Sweitzer, PhD (1) · McNeil AB (1) · National Institute on Aging (NIA) (1) · Neuraltus Pharmaceuticals, Inc. (1) · Ohio State University (1) · Ohio State University Comprehensive Cancer Center (1) · Parc de Salut Mar (1) · Pharmaceutical Productions Inc. (1) · University of California, Los Angeles (1)
United States (34) · Sweden (2) · Spain (1) · United Kingdom (1)
Mehmet Sofuoglu, M.D., Ph.D. (2) · Abrahan N Lieberman, MD (1) · Alexander C Conley, PhD (1) · Carol Myers, Ph.D. (1) · Christopher B Harte, MA (1) · Dana Cavallo, Ph.D. (1) · Dana Cavallo, PhD (1) · Deepak C D'Souza, M.D. (1) · Dustin C Lee, Ph.D. (1) · Edythe D London, Ph.D. (1) · Elisabeth Kruse, PhD (1) · Erik Lunell, MD, PhD (1) · Frank Vocci, Ph.D (1)
PMID 22717030, PMID 24075893, PMID 25361769, PMID 30027479, PMID 31133957, PMID 32297782, PMID 33089005, PMID 34029565, PMID 38152462, PMID 40489161, PMID 41249021
U54DA036151 (4), K23DA039294 (1), R01AG022462 (1), R01DA003890 (1), R01DA008075 (1), R01DA055962 (1), R01DA057282 (1), R03DA027474 (1), R21DA044377 (1), R41DA033710 (1)